Microvesicles-mediated Cell Communication in Pulmonary Arterial Hypertension

Lei Chen1, Ying-Jian Gu1, Ming-Yuan Zhou1

  • 1Department of Clinical Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning110122, China.

Current Medicinal Chemistry
|November 25, 2020
PubMed
Abstract

Insights

Microvesicles mediate cell communication and are implicated in pulmonary arterial hypertension pathogenesis. Targeting microvesicle communication offers a potential therapeutic strategy for this chronic lung disease.

Area of Science:

  • Cellular Biology
  • Biomedical Science
  • Pathophysiology

Background:

  • Pulmonary arterial hypertension (PAH) is a chronic disease impacting human health.
  • Microvesicles facilitate intercellular communication by transferring bioactive molecules, influencing immunity and angiogenesis.
  • Microvesicles are explored as diagnostic biomarkers and therapeutic targets for diseases like PAH.

Purpose of the Study:

  • To elucidate the classification, features, and mechanisms of microvesicle-mediated cell communication.
  • To investigate the role of microvesicle communication in the context of pulmonary arterial hypertension.

Main Methods:

  • Literature review on microvesicle function and PAH.
  • Analysis of studies detailing microvesicle involvement in cellular processes.
  • Examination of research on microvesicles in inflammatory pathways.

Main Results:

  • Inflammation is a key factor in PAH development.
  • Microvesicles derived from various cells contribute to PAH pathology by transferring inflammatory factors.
  • Microvesicle-mediated transfer of inflammatory mediators plays a role in PAH progression.

Conclusions:

  • Microvesicle-mediated cell communication is integral to PAH.
  • Targeting microvesicle communication presents a promising therapeutic avenue for pulmonary arterial hypertension.